bioAffinity (BIAF) S-1 IPO registration

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

bioAffinity Technologies, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type	Security Class Title	Fee Calculation or Carry Forward Rule			Amount Registered			Proposed Maximum Offering Price Per Unit		Maximum Aggregate Offering Price			Fee Rate		Amount of Registration Fee
Fees to be Paid	Equity	Common Stock, $0.000142857142857 par value per share(1)		457	(o)		—			—	$	15,000,000 (2)			0.0000927	$	1390.50	(7)
		Over-Allotment Option		457	(o)						$	2,250,000	(2)(3)		0.0000927		208.58	(7)
	Other	Representative’s Warrants(4)		457	(g)		—			—		—			—		—
	Equity	Common Stock, $0.0001 par value per share, issuable upon exercise of the Representative’s Warrants(5)		457	(o)		—			—	$	1,587,000	(2)		0.0000927	$	147.11	(7)
	Other	Placement Agent’s Warrants(4)		457	(g)		—			—		—			—		—
	Equity	Common Stock, $0.0001 par value per share, issuable upon exercise of the Placement Agent’s Warrants(6)		457	(a)		369,791	(8)				—			0.0000927		—
		Total Offering Amount									$	18,837,000				$	1,746.19
		Total Fees Previously Paid														$	—
		Net Fee Due														$	1,746.19

(1)	This registration statement also includes an indeterminate number of securities that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).
(2)	Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act.
(3)	Includes the offering price of additional shares that the underwriters have the option to purchase to cover over-allotments, if any.
(4)	No fee required pursuant to Rule 457(g) under the Securities Act.
(5)	Represents warrants to purchase a number of securities equal to 8% of the shares of Common Stock sold in this offering at an exercise price equal to 115% of the public offering price per share.
(6)	Represents warrants to purchase 369,791 shares of Common Stock issued to our Placement Agent at an exercise price equal to the price in this Offering or $0.75 per share if the Company does not complete an initial public offering by the warrants’ maturity date.
(7)	Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.
(8)	To be calculated and paid in accordance with Rule 457(a) under the Securities Act when the price in this Offering is determined.